KOREA PHARMA CO., LTD.

Otros idiomas KOREA PHARMA Co., Ltd.

Acciones

A032300

KR7032300006

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 26/06/2024			Varia. Cinco días.	Varia. 1 de enero.
18.000 ^KRW	-0,17 %		-2,07 %	-23,89 %

28/05	NetScientific respalda a Wanda; Inspirit Energy consigue un acuerdo	AN
28/05	Korea Pharma Co., Ltd presenta una solicitud de nuevo fármaco al Ministerio coreano de Seguridad Alimentaria y Farmacéutica para la revisión y aprobación de Accrufer para el tratamiento de pacientes con anemia ferropénica en Corea	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

NetScientific backs Wanda; Inspirit Energy wins deal	28/05
Korea Pharma Co., Ltd Submits A New Drug Application to the Korean Ministry of Food and Drug Safety for the Review and Approval of Accrufer to Treat Patients with Iron Deficiency Anaemia in Korea	28/05
Astrogen Co.,Ltd. announced that it has received KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	30/11
KOREA PHARMA Co., Ltd. announced that it has received KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd.	28/11
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd. and others	24/11
Astrogen Co.,Ltd. announced that it expects to receive KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	14/11
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) dropped from S&P Global BMI Index	18/09/23
KOREA PHARMA Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Shield Therapeutics plc - Full Year Trading Update	10/02/23
Shield announces regulatory pathway and timelines for Accrufer approval in the Republic of Korea	01/11/22
KOREA PHARMA Co., Ltd. announced that it has received KRW 50 billion in funding	26/10/21
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 50 billion in funding	22/10/21
Shield Therapeutics : Licence agreement secured in Republic of Korea for Accrufer	08/10/21
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) added to S&P Global BMI Index	20/09/21
KOREA PHARMA Co., Ltd. has completed an IPO in the amount of KRW 29.187 billion.	04/08/20
KOREA PHARMA Co., Ltd. has filed an IPO.	13/04/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Nuestros Contenidos Gratuitos le Ayudan a Asegurar y Aumentar el Rendimiento de sus Inversiones

Asegurar mis Inversiones

fermer